ASX - By Stock
|
BOT |
Re:
Ann: Botanix $70 Million Institutional Capital Raising
|
|
ezskins
|
235 |
84K |
17 |
21/06/24 |
21/06/24 |
ASX - By Stock
|
235
|
84K
|
17
|
|
ASX - By Stock
|
BOT |
Re:
Ann: FDA Approves Sofdra
|
|
ezskins
|
501 |
169K |
8 |
20/06/24 |
20/06/24 |
ASX - By Stock
|
501
|
169K
|
8
|
|
ASX - By Stock
|
BOT |
Re:
Ann: FDA Approves Sofdra
|
|
ezskins
|
501 |
169K |
21 |
20/06/24 |
20/06/24 |
ASX - By Stock
|
501
|
169K
|
21
|
|
ASX - By Stock
|
BOT |
Re:
Ann: Trading Halt
|
|
ezskins
|
316 |
91K |
6 |
25/09/23 |
25/09/23 |
ASX - By Stock
|
316
|
91K
|
6
|
|
ASX - By Stock
|
BOT |
Re:
Post-FDA decision price sweep
|
|
ezskins
|
124 |
35K |
3 |
15/09/23 |
15/09/23 |
ASX - By Stock
|
124
|
35K
|
3
|
|
ASX - By Stock
|
BOT |
Re:
Ann: Trading Halt
|
|
ezskins
|
232 |
67K |
15 |
03/04/23 |
03/04/23 |
ASX - By Stock
|
232
|
67K
|
15
|
|
ASX - By Stock
|
BOT |
Re:
Ann: Dermatology Asset Acquired to Accelerate Path to Revenue
|
|
ezskins
|
151 |
58K |
33 |
04/05/22 |
04/05/22 |
ASX - By Stock
|
151
|
58K
|
33
|
|
ASX - By Stock
|
BOT |
Re:
Ann: New Canine Pilot Study Supports Further AD Investigation
|
|
ezskins
|
60 |
22K |
10 |
17/05/21 |
17/05/21 |
ASX - By Stock
|
60
|
22K
|
10
|
|
ASX - By Stock
|
BOT |
Re:
Ann: Phase 2a Study Shows BTX 1801 Eradicates S. Aureus
|
|
ezskins
|
1K |
292K |
2 |
03/02/21 |
03/02/21 |
ASX - By Stock
|
1K
|
292K
|
2
|
|
ASX - By Stock
|
BOT |
Re:
Ann: Phase 2a Study Shows BTX 1801 Eradicates S. Aureus
|
|
ezskins
|
1K |
292K |
3 |
03/02/21 |
03/02/21 |
ASX - By Stock
|
1K
|
292K
|
3
|
|
ASX - By Stock
|
BOT |
Re:
Ann: Phase 2a Study Shows BTX 1801 Eradicates S. Aureus
|
|
ezskins
|
1K |
292K |
3 |
03/02/21 |
03/02/21 |
ASX - By Stock
|
1K
|
292K
|
3
|
|
ASX - By Stock
|
BOT |
Re:
Ann: Antimicrobial Data Published in Peer-Reviewed Journal
|
|
ezskins
|
233 |
84K |
16 |
20/01/21 |
20/01/21 |
ASX - By Stock
|
233
|
84K
|
16
|
|
ASX - By Stock
|
BOT |
Re:
Announcement date and opening price
|
|
ezskins
|
370 |
131K |
1 |
14/01/21 |
14/01/21 |
ASX - By Stock
|
370
|
131K
|
1
|
|
ASX - By Stock
|
BOT |
Re:
BOT - Anything but charting
|
|
ezskins
|
9.0K |
3.4M |
19 |
11/01/21 |
11/01/21 |
ASX - By Stock
|
9.0K
|
3.4M
|
19
|
|
ASX - By Stock
|
BOT |
Re:
33c share price target by July 2021
|
|
ezskins
|
273 |
127K |
11 |
16/07/20 |
16/07/20 |
ASX - By Stock
|
273
|
127K
|
11
|
|
ASX - By Stock
|
BOT |
Re:
Ann: Botanix Announces Top Line BTX 1204 Atopic Dermatitis Data
|
|
ezskins
|
211 |
106K |
5 |
25/03/20 |
25/03/20 |
ASX - By Stock
|
211
|
106K
|
5
|
|
ASX - By Stock
|
BOT |
Re:
Ann: Trading Halt
|
|
ezskins
|
78 |
37K |
8 |
25/03/20 |
25/03/20 |
ASX - By Stock
|
78
|
37K
|
8
|
|
ASX - By Stock
|
PCK |
Re:
PainChek General Discussion
|
|
ezskins
|
20K |
16M |
4 |
30/01/20 |
30/01/20 |
ASX - By Stock
|
20K
|
16M
|
4
|
|
ASX - By Stock
|
PCK |
Re:
Ann: Appendix 4C - quarterly
|
|
ezskins
|
5 |
7.1K |
6 |
30/01/20 |
30/01/20 |
ASX - By Stock
|
5
|
7.1K
|
6
|
|
ASX - By Stock
|
BOT |
Re:
Ann: Botanix Attends USA Healthcare Conferences
|
|
ezskins
|
48 |
31K |
6 |
13/01/20 |
13/01/20 |
ASX - By Stock
|
48
|
31K
|
6
|
|
ASX - By Stock
|
BOT |
Re:
Ann: Botanix Attends USA Healthcare Conferences
|
|
ezskins
|
48 |
31K |
3 |
13/01/20 |
13/01/20 |
ASX - By Stock
|
48
|
31K
|
3
|
|
ASX - By Stock
|
BOT |
Re:
Ann: Botanix Announces De-scheduling of Synthetic CBD
|
|
ezskins
|
115 |
55K |
12 |
25/11/19 |
25/11/19 |
ASX - By Stock
|
115
|
55K
|
12
|
|
ASX - By Stock
|
RNU |
Re:
Ann: Battery-Grade Graphite Produced via Low-Cost Purification
|
|
ezskins
|
22 |
11K |
1 |
18/11/19 |
18/11/19 |
ASX - By Stock
|
22
|
11K
|
1
|
|
ASX - By Stock
|
IMU |
Re:
Its done! Vaxinia takeover strongly approved by IMU shareholders!
|
|
ezskins
|
147 |
105K |
2 |
18/11/19 |
18/11/19 |
ASX - By Stock
|
147
|
105K
|
2
|
|
ASX - By Stock
|
RNU |
Re:
Ann: Battery-Grade Graphite Produced via Low-Cost Purification
|
|
ezskins
|
22 |
11K |
5 |
18/11/19 |
18/11/19 |
ASX - By Stock
|
22
|
11K
|
5
|
|
ASX - By Stock
|
IMU |
Re:
Monday Extraordinary Gen Mtg Dial In
|
|
ezskins
|
9 |
8.1K |
1 |
15/11/19 |
15/11/19 |
ASX - By Stock
|
9
|
8.1K
|
1
|
|
ASX - By Stock
|
RNU |
Re:
Ann: Siviour Definitive Feasibility Study Presentation
|
|
ezskins
|
25 |
11K |
8 |
11/11/19 |
11/11/19 |
ASX - By Stock
|
25
|
11K
|
8
|
|
ASX - By Stock
|
BOT |
Re:
Ann: BTX 1503 Acne Phase 2 Study Results Presentation
|
|
ezskins
|
650 |
327K |
5 |
23/10/19 |
23/10/19 |
ASX - By Stock
|
650
|
327K
|
5
|
|
ASX - By Stock
|
BOT |
Re:
Ann: Botanix Announces BTX 1503 Data and Progression to Phase 3
|
|
ezskins
|
402 |
243K |
12 |
23/10/19 |
23/10/19 |
ASX - By Stock
|
402
|
243K
|
12
|
|
ASX - By Stock
|
BOT |
Re:
Ann: Botanix Announces BTX 1503 Data and Progression to Phase 3
|
|
ezskins
|
402 |
243K |
8 |
22/10/19 |
22/10/19 |
ASX - By Stock
|
402
|
243K
|
8
|
|
ASX - By Stock
|
BOT |
Re:
Ann: Botanix Announces BTX 1503 Data and Progression to Phase 3
|
|
ezskins
|
402 |
243K |
22 |
22/10/19 |
22/10/19 |
ASX - By Stock
|
402
|
243K
|
22
|
|
ASX - By Stock
|
BOT |
Re:
Ann: Trading Halt
|
|
ezskins
|
146 |
90K |
8 |
22/10/19 |
22/10/19 |
ASX - By Stock
|
146
|
90K
|
8
|
|